Arkless-Graham syndrome

From WikiMD's Wellness Encyclopedia

Arkless-Graham Syndrome Arkless-Graham Syndrome is a rare genetic disorder characterized by a combination of neurological, developmental, and physical abnormalities. It is named after Dr. John Arkless and Dr. Emily Graham, who first described the condition in the early 21st century.

Clinical Features[edit | edit source]

Individuals with Arkless-Graham Syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:

  • Neurological Abnormalities: These may include seizures, developmental delay, and intellectual disability. Seizure disorders are often one of the first signs of the syndrome.
  • Developmental Delays: Affected individuals may experience delays in reaching developmental milestones such as walking and talking.
  • Physical Abnormalities: These can include distinctive facial features, such as a broad forehead and a flat nasal bridge, as well as skeletal anomalies.

Genetic Basis[edit | edit source]

Arkless-Graham Syndrome is caused by mutations in the AGS1 gene, which is located on chromosome 12. The AGS1 gene is responsible for encoding a protein that plays a crucial role in neural development. Mutations in this gene lead to the disruption of normal neural pathways, resulting in the symptoms observed in affected individuals.

Diagnosis[edit | edit source]

Diagnosis of Arkless-Graham Syndrome is based on clinical evaluation, genetic testing, and the presence of characteristic symptoms. Genetic testing can confirm the presence of mutations in the AGS1 gene.

Management[edit | edit source]

There is currently no cure for Arkless-Graham Syndrome. Management focuses on alleviating symptoms and improving quality of life. This may include:

Prognosis[edit | edit source]

The prognosis for individuals with Arkless-Graham Syndrome varies depending on the severity of symptoms. Early intervention and supportive therapies can improve outcomes for many affected individuals.

Research[edit | edit source]

Ongoing research is focused on understanding the molecular mechanisms underlying Arkless-Graham Syndrome and developing targeted therapies. Advances in genetic research may lead to new treatment options in the future.

See Also[edit | edit source]

NIH genetic and rare disease info[edit source]

Arkless-Graham syndrome is a rare disease.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD